Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Harmony Biosciences Holdings, Inc. - Common Stock (NQ:HRMY)

34.08 -0.34 (-0.99%)
Delayed Quote Updated: 9:38 AM EST, Nov 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 31,071
Open 35.68
Bid (Size) 34.05 (100)
Ask (Size) 34.35 (100)
Prev. Close 34.42
Today's Range 34.06 - 35.68
52wk Range 25.90 - 43.49
Shares Outstanding 57,031,297
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Harmony Biosciences (HRMY) Q3 2026 Earnings Call Transcript ↗
CEO succession and BP-205 early data shape the quarter's outlook. 
Via The Motley Fool
Topics Earnings
News headline image
Harmony Biosciences Q3 Earnings Call Highlights ↗
Harmony Biosciences (NASDAQ:HRMY) reported third-quarter net revenue of $269 million, up from $239 million a year earlier, as demand for its narcolepsy treatment WAKIX continued to grow. The company... 
Via MarketBeat
Topics Earnings Economy Intellectual Property

Performance

52-Week Range 21.6% below 52-week high
34.08
25.9052W Low 43.4952W High
1 Week 13.1% below 1-week high
32.611W Low 39.201W High

Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) traded between $25.90 and $43.49 over the past 52 weeks and last traded at $34.08, 21.6% below its 52-week high. Over the past week it ranged between $32.61 and $39.20.

Past 12 Months
-11.7%
-14.6%
-10.9%
+4.0%
-8.8%
+10.9%
1W -$4.51
1M -$5.84
3M -$4.16
6M +$1.30
YTD -$3.30
1Y +$3.36

HRMY was +10.9% over the past year, +4.0% over six months, -8.8% year to date, -11.7% in the last week.

12 Months vs Market
HRMY
+10.9%
DIA
+12.7%
SPY
+12.0%
QQQ
+9.1%
IWM
+16.5%

Over the past 12 months HRMY returned +10.9% versus DIA (Dow) +12.7%, SPY (S&P 500) +12.0%, QQQ (Nasdaq 100) +9.1% and IWM (Russell 2000) +16.5%.

Volume & Liquidity 0.03× 3-mo avg
Today 31,071 3-mo avg 977.6K
1W
1.3M
1M
1.1M
3M
977.6K
6M
917.5K
YTD
897.3K
1Y
878.5K

HRMY most recently traded 31,071 shares against a 3-month average daily volume of 977.6K.

More News

Read More
Harmony Biosciences Holdings (NASDAQ:HRMY) Q3 2026 Earnings Miss Overshadows WAKIX Growth ↗
Via Chartmill
Topics Earnings
News headline image
Harmony Biosciences Reports Q3 Financial Results on Track to Achieve More Than $1 Billion WAKIX Net Revenue and Announces Strong Multiple-Ascending Dose Data for Its Orexin Agonist BP-205, Supporting Potential Best-in-Class Profile
From Harmony Biosciences
Via GlobeNewswire
Harmony Biosciences Holdings (NASDAQ:HRMY): A Value Stock with Strong Financial Health ↗
Via Chartmill
Harmony Biosciences Holdings (NASDAQ:HRMY) Q1 Revenue Meets Guidance, But EPS Miss and Elevated Spending Weigh on Shares ↗
Via Chartmill
News headline image
4 Small-Cap Stocks With Paths to Recovery After the Fed's September Rate Hike ↗
Via MarketBeat
Topics Economy
News headline image
Harmony Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026
From Harmony Biosciences
Via GlobeNewswire
News headline image
Why Harmony Biosciences Stock Got Mashed on Monday ↗
Via The Motley Fool
News headline image
Harmony Biosciences Announces Planned CEO Transition to Support Next Phase of Growth
From Harmony Biosciences
Via GlobeNewswire
News headline image
Harmony Biosciences Announces Poster Presentation at the 17th European Narcolepsy Days
From Harmony Biosciences
Via GlobeNewswire
News headline image
Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress
From Harmony Biosciences
Via GlobeNewswire
News headline image
Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference
From Harmony Biosciences
Via GlobeNewswire
News headline image
Harmony Biosciences Highlights Record WAKIX Growth, Advances Orexin and Epilepsy Pipeline ↗
Via MarketBeat
News headline image
Harmony Biosciences (HRMY) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Harmony Biosciences to Participate in Piper Sandler Virtual CNS Symposium
From Harmony Biosciences
Via GlobeNewswire
News headline image
Harmony Biosciences Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Harmony Biosciences Announces Record Q2 2026 Revenue and Shares Initial Clinical Data for Its Orexin-2 Agonist BP-205 Reinforcing Potential Best-in-Class Profile
From Harmony Biosciences
Via GlobeNewswire
News headline image
Harmony Biosciences To Report Second Quarter 2026 Financial Results On August 4, 2026
From Harmony Biosciences
Via GlobeNewswire
News headline image
Harmony Biosciences Preannounces Record Quarterly Revenue for Q2 2026, Reaffirms Full-Year 2026 Revenue Guidance, and Announces CFO Transition
From Harmony Biosciences Holdings, Inc.
Via Business Wire
News headline image
Harmony Biosciences Announces Poster Presentations at 2026 SLEEP Annual Meeting
From Harmony Biosciences Holdings, Inc.
Via Business Wire
News headline image
Harmony (HRMY) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Harmony Biosciences to Participate in Upcoming Investor Conferences
From Harmony Biosciences Holdings, Inc.
Via Business Wire
News headline image
A Healthcare Fund Just Made Bitgo Its Biggest Bet ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
A beaten-down biotech just lost a meaningful backer — should you care? ↗
Via The Motley Fool
Topics Regulatory Compliance

Frequently Asked Questions

Is Harmony Biosciences Holdings, Inc. - Common Stock publicly traded?
Yes, Harmony Biosciences Holdings, Inc. - Common Stock is publicly traded.
What exchange does Harmony Biosciences Holdings, Inc. - Common Stock trade on?
Harmony Biosciences Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Harmony Biosciences Holdings, Inc. - Common Stock?
The ticker symbol for Harmony Biosciences Holdings, Inc. - Common Stock is HRMY on the Nasdaq Stock Market
What is the current price of Harmony Biosciences Holdings, Inc. - Common Stock?
The current price of Harmony Biosciences Holdings, Inc. - Common Stock is 34.08
When was Harmony Biosciences Holdings, Inc. - Common Stock last traded?
The last trade of Harmony Biosciences Holdings, Inc. - Common Stock was at 11/05/26 09:38 AM ET
What is the market capitalization of Harmony Biosciences Holdings, Inc. - Common Stock?
The market capitalization of Harmony Biosciences Holdings, Inc. - Common Stock is 1.94B
How many shares of Harmony Biosciences Holdings, Inc. - Common Stock are outstanding?
Harmony Biosciences Holdings, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.